China Universal Asset Management Company’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Sell |
136,536
-6,590
| -5% | -$74.3K | 0.14% | 130 |
|
|
2025
Q1 | $1.44M | Sell |
143,126
-11,226
| -7% | -$113K | 0.13% | 141 |
|
|
2024
Q4 | $1.83M | Buy |
154,352
+12,118
| +9% | +$143K | 0.17% | 111 |
|
|
2024
Q3 | $1.64M | Buy |
142,234
+55,445
| +64% | +$640K | 0.18% | 108 |
|
|
2024
Q2 | $917K | Sell |
86,789
-68,121
| -44% | -$720K | 0.13% | 109 |
|
|
2024
Q1 | $1.63M | Buy |
154,910
+61,921
| +67% | +$653K | 0.21% | 92 |
|
|
2023
Q4 | $1.04M | Buy |
92,989
+73,192
| +370% | +$822K | 0.2% | 105 |
|
|
2023
Q3 | $231K | Buy |
19,797
+9,856
| +99% | +$115K | 0.07% | 140 |
|
|
2023
Q2 | $100K | Sell |
9,941
-335
| -3% | -$3.38K | 0.03% | 154 |
|
|
2023
Q1 | $75.8K | Buy |
10,276
+2,907
| +39% | +$21.5K | 0.03% | 140 |
|
|
2022
Q4 | $58.9K | Buy |
+7,369
| New | +$58.9K | 0.02% | 133 |
|